| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Neurology Service (127), Veterans Affairs Medical Center, and the Departments of Neurology and Anatomy, University of Utah School of Medicine, Salt Lake City, UT.
We reacted dispersed cultures of newborn rat cerebellar granule cells with serum, purified IgG, and CSF from patients with type Ha ("anti-Hu") antibody response accompanying paraneoplastic neurologic syndromes. All type Ha sera, IgGs, and CSFs, but not those of normal or cancer controls, produced bright nuclear immunofluorescence of cultured granule neurons. Type Ha serum and CSF labeled proteins of 35-42 kd in rat granule cell blots, identical in molecular weight to proteins labeled by type IIa antibodies in blots of human granule cells. IgGs eluted from the 35-42 kd band in blots of rat granule cells labeled proteins of similar molecular weights in blots of human granule cells and produced typical type IIa immunostaining of human cerebellar sections. Human IgG could be identified in nuclei and cytoplasm of neurons incubated for 72 hours with 2/4 type IIa sera tested, but not with normal sera. Type IIa sera or IgGs from 4/7 patients produced specific lysis of rat granule cells in the presence of complement, as compared with controls using normal serum or heat-inactivated complement. Prolonged (7-day) incubation of cultures with type IIa antibody without complement also resulted in specific lysis, whereas incubation with normal serum or serum from neurologically normal patients with small-cell carcinoma of the lung did not. Rat granule cell cultures provide a valuable in vitro system with which to study the interaction of type IIa antibody with neurons. The present study provides the first reported evidence that type IIa antibodies may cause cell injury directly, in the absence of lymphocyte-mediated immune response.
Address correspondence and reprint requests to Dr. John E. Greenlee, Neurology Service (127), Veterans Affairs Medical Center, Salt Lake City, UT 84148.
Supported by a Merit Review Award from the United States Department of Veterans Affairs. Dr. Jaeckle is a recipient of USPHS/CA award RO1CA53464.
Received October 1, 1992. Accepted for publication in final form February 3,1993.
This article has been cited by other articles:
|
|
 |
|
  D. Ricard, V. Rogemond, E. Charrier, M. Aguera, D. Bagnard, M.-F. Belin, N. Thomasset, and J. Honnorat Isolation and Expression Pattern of Human Unc-33-Like Phosphoprotein 6/Collapsin Response Mediator Protein 5 (Ulip6/CRMP5): Coexistence with Ulip2/CRMP2 in Sema3A- Sensitive Oligodendrocytes J. Neurosci., September 15, 2001; 21(18): 7203 - 7214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Maruyama, H. Ohguro, and Y. Ikeda Retinal Ganglion Cells Recognized by Serum Autoantibody against {gamma}-Enolase Found in Glaucoma Patients Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1657 - 1665. [Abstract] [Full Text]
|
|
|
|
|
|
H. Ohguro, K.-i. Ogawa, T. Maeda, A. Maeda, and I. Maruyama Cancer-Associated Retinopathy Induced by Both Anti-Recoverin and Anti-hsc70 Antibodies In Vivo Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3160 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R D VOLTZ, J B POSNER, J DALMAU, J B POSNER, J DALMAU, and F GRAUS Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour J. Neurol. Neurosurg. Psychiatry, August 1, 1997; 63(2): 133 - 136. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
